Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > if i was rich

<< Previous

Bullboard Posts

Next >>

Comment by saintpeteron Dec 28, 2020 7:05am

77 Views

Post# 32186565

RE:RE:if i was rich

Well said Blig if we could just get people in general to just think about that more we have a good chance of slowing this crapp down and the sooner we can hopefully enjoy life again a small sacrifice IMO

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading